Inka Caesar
Impact in
- Genetics top 10%
- Inflammatory Bowel Disease
- Gastroenterology top 10%
- Gastrointestinal motility and disorders
Papers in
- Genetics 11
- Inflammatory Bowel Disease 11
-
- Microscopic Colitis 7
- Autoimmune and Inflammatory Disorders 2
- Co-authors
- Tilo Andus (14 shared papers)Jürgen Schölmerich (10 shared papers)Michael Roth (6 shared papers)Volker Groß (5 shared papers)M Gierend (5 shared papers)Frank Kullmann (1 shared paper)Stefan Feuerbach (1 shared paper)A. Geißler (1 shared paper)
In The Last Decade
Inka Caesar
17 papers receiving 584 citations
Peers
Comparison fields: 5 of 64
- Genetics 383
- Gastroenterology 53
- Epidemiology 218
- Immunology 101
- Rheumatology 45
Countries citing papers authored by Inka Caesar
This map shows the geographic impact of Inka Caesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inka Caesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inka Caesar more than expected).
Fields of papers citing papers by Inka Caesar
This network shows the impact of papers produced by Inka Caesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inka Caesar. The network helps show where Inka Caesar may publish in the future.
Co-authors
The 25 scholars most cited alongside Inka Caesar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 266 | |
| 2 | 1995 | 108 | |
| 3 | Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. | 1996 | 91 |
| 4 | 1993 | 30 | |
| 5 | 2004 | 26 | |
| 6 | Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. | 1999 | 22 |
| 7 | 1996 | 21 | |
| 8 | Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. | 1997 | 20 |
| 9 | Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. | 1995 | 10 |
| 10 | 1998 | 10 | |
| 11 | 1998 | 9 | |
| 12 | [Transitory increase of the thyroid stimulating hormone in the newborn after polyvinylpyrrolidon-iodine application during parturition (author's transl)]. | 1979 | 3 |
| 13 | 1997 | 2 | |
| 14 | 1998 | 2 | |
| 15 | 1992 | 1 | |
| 16 | 1998 | 1 | |
| 17 | 1995 | 1 |
About Inka Caesar
Inka Caesar is a scholar working on Genetics, Epidemiology, Gastroenterology, Surgery and Hepatology, having authored 17 papers that have together received 623 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers), Celiac Disease Research and Management (2 papers), Autoimmune and Inflammatory Disorders (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Thyroid Disorders and Treatments (1 paper), Liver Diseases and Immunity (1 paper) and Blood properties and coagulation (1 paper). The work is most often cited by research in Genetics (383 citations), Gastroenterology (53 citations), Epidemiology (218 citations), Immunology (101 citations) and Rheumatology (45 citations). Inka Caesar has collaborated with scholars based in Germany and Austria. Frequent co-authors include Tilo Andus, Jürgen Schölmerich, Michael Roth, Volker Groß, M Gierend, Frank Kullmann, Stefan Feuerbach, A. Geißler, Paul G. Held and K. Ewe. Their work appears in journals such as Gastroenterology, International Journal of Colorectal Disease, European Journal of Gastroenterology & Hepatology, Digestive Diseases and Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.